Patient passed away unexpectedly [death nos].Case narrative: upon internal review on 7-jun-2018, this case was found out to be a duplicate of (b)(4), hence prepared for deletion.Initial information was received on 07-jun-2018 regarding this unsolicited case from united states via a health professional.This case involves a patient of unknown demographics who passed away unexpectedly (latency: unknown), after he/she was treated with hylan g-f 20, sodium hyaluronate (synvisc one).The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.On an unknown date in 2018, the patient received intra-articular hylan g-f 20, sodium hyaluronate (synvisc one) injection once at a dose of 6 ml (lot - 7rsl047, exp date: 31-oct-2020) for unilateral primary osteoarthritis.On (b)(6) 2018, the patient passed away unexpectedly following the first dose intake.Final diagnosis was (fatal) patient passed away unexpectedly.It is unknown if an autopsy was done.
|